mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
0.31 |
0.01 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.01 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |